Ross S Francis
Overview
Explore the profile of Ross S Francis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
477
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Humphries T, Lee S, Urquhart A, Vesey D, Micallef A, Winterford C, et al.
Physiol Rep
. 2025 Feb;
13(4):e70249.
PMID: 39957082
Tubulointerstitial fibrosis is a characteristic hallmark of chronic kidney disease (CKD). Metabolic perturbations in cellular energy metabolism contribute to the pathogenesis of CKD, but the chemical contributors remain unclear. The...
2.
Pham U, Pryke A, Baskerville T, Griffin A, Whiddett R, Fotheringham A, et al.
J Clin Endocrinol Metab
. 2024 Nov;
PMID: 39527041
Objectives: To examine the relationship between kidney hyperfiltration during adolescence and subsequent changes in estimated glomerular filtration rate (eGFR) and urinary albumin creatinine ratio (UACR) in a young cohort of...
3.
Humphries T, Gobe G, Urquhart A, Ellis R, Galloway G, Vesey D, et al.
NMR Biomed
. 2024 Sep;
37(12):e5257.
PMID: 39229964
This study aimed to investigate the metabolic changes in the kidneys in a murine adenine-diet model of chronic kidney disease (CKD). Kidney fibrosis is the common pathological manifestation across CKD...
4.
5.
Ng M, Kaur G, Francis R, Hawley C, Johnson D
Nat Rev Nephrol
. 2024 Jul;
20(11):707-721.
PMID: 39085415
Drug repurposing in glomerular disease can deliver opportunities for steroid-free regimens, enable personalized multi-target options for resistant or relapsing disease and enhance treatment options for understudied populations (for example, children)...
6.
Ethier I, Hayat A, Pei J, Hawley C, Johnson D, Francis R, et al.
Cochrane Database Syst Rev
. 2024 Jun;
6:CD013800.
PMID: 38899545
Background: Peritoneal dialysis (PD) and haemodialysis (HD) are two possible modalities for people with kidney failure commencing dialysis. Only a few randomised controlled trials (RCTs) have evaluated PD versus HD....
7.
Chan S, Wood D, Hawley C, Campbell K, Campbell S, Cao C, et al.
Clin Transplant
. 2023 Oct;
38(1):e15175.
PMID: 37902121
No abstract available.
8.
Weerasekera S, Reid N, Young A, Homes R, Sia A, Giddens F, et al.
Transplant Direct
. 2023 Oct;
9(11):e1548.
PMID: 37854024
Background: Clinical Practice Guidelines suggest that frailty be measured during kidney transplant eligibility assessments. Yet it is not known how frailty is best assessed in this setting or whether its...
9.
King S, Reid N, Brown S, Brodie L, Sia A, Chatfield M, et al.
BMC Geriatr
. 2023 Oct;
23(1):664.
PMID: 37845618
Background: Frailty is prevalent in older people with chronic kidney disease (CKD) and robust evidence supporting the benefit of dialysis in this setting is lacking. We aimed to measure frailty...
10.
Humphries T, Vesey D, Galloway G, Gobe G, Francis R
Prog Nucl Magn Reson Spectrosc
. 2023 Jun;
134-135:52-64.
PMID: 37321758
Chronic kidney disease (CKD) affects approximately 10% of the world population, higher still in some developing countries, and can cause irreversible kidney damage eventually leading to kidney failure requiring dialysis...